fda label semaglutide naion warning 2025 U.S. | The FDA has approved a new higher dose (7.2 mg) of Wegovy ( semaglutide) injection, Wegovy HD, for weight loss and long-term weight The Double-Edged Sword: Ozempic For

Side effects Another thing to consider with these weight loss drugs is the potential side effects

Common Side Effects The primary side effects are gastrointestinal: Nausea: Affects 20-40% of patients, usually improving over weeks as the body adjusts

For weight management, semaglutide is typically administered at a higher dose compared to its use for diabetes

Stillbirth rates are also slightly elevated at 0.6-1.0% compared to 0.4-0.6% in women without these conditions

: Wegovy an adjunct to diet and exercise to reduce body weight an maintain weight reduction to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established cardiovascular disease and either obesity or overweight